Evidence map›Paper›PMID 20972329›Full record

ArticleThe Journal of clinical investigation2010

Pharmacologic eigenvalues: beating the rap on bone marrow failure.

Stephen G Emerson, Russell W Garrett

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephen G EmersonDepartment of Biology, Haverford College, Haverford, Pennsylvania 19041, USA. semerson@haverford.edu
Russell W Garrett
Haverford College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients suffering from sustained acute or chronic illness often have decreased white blood cell and platelet counts as well as anemia, and bone marrow studies routinely show only decreased numbers of blood precursor cells. While much has been recently learned about the cause of isolated anemia, the pathogenesis of true bone marrow failure (i.e., low bone marrow cellularity and low counts in multiple blood lineages) has remained elusive. In this issue of the JCI, Chen et al. present evidence that overactivation of mammalian target of rapamycin signaling in HSCs is found in two mouse models of bone marrow failure, and they show that treatment with rapamycin significantly normalizes the low blood counts.

Indexed as

Bone MarrowHematopoietic Stem CellsAnemiaAnimalsHematopoiesisHumansImmunity, InnateImmunosuppressive AgentsIntercellular Signaling Peptides and ProteinsMiceMyelodysplastic SyndromesSignal TransductionSirolimusTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaImmunosuppressive AgentsIntercellular Signaling Peptides and ProteinsSirolimusTOR Serine-Threonine KinasesTumor Necrosis Factor-alpha

Identifiers

PMID20972329
PMCPMC2965004
OpenAlexW2007088813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.